7 results
Map of proliferative blood disorders. 

By Ariella Coler-Reilly @ariellastudies

#Algorithm #classification #proliferative #blood #disorders #leukemia #hematology #oncology
Map of proliferative ... ariellastudies #Algorithm ... #classification ... disorders #leukemia #hematology ... #CLL #AML #Map
Platelet disorders and Aggregometry
Glanzmann Thrombasthenia
 • Defective aggregation to all agonists except ristocetin
 • Normal platelet,
aggregation to all ... ) is absent or dysfunctional ... ; may be normal ... Platelet #disorders #hematology ... #hemepath #differential
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
Macrophage Activation ... nervous system (CNS) dysfunction ... 5000 to 10,000 ng/mL ... #Macrophage #Activation ... Diagnosis #Management #Hematology
Hepatorenal Syndrome (HRS)

Definition:
• Functional, potentially reversible kidney impairment.
• Occurs in advanced liver disease: cirrhosis, severe alcoholic
sympathetic + ADH activation ... Classification: ... Norepinephrine may ... evaluation essential in all ... Hepatorenal #Syndrome #Hepatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Malignancy (e.g. hematologic ... erythematosus (NPSLE): • May ... mild cognitive dysfunction ... Chronic B-cell activation
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
cytopenias and organ dysfunction ... Persistent fever, organ dysfunction ... • In all patients ... (often termed MAS-HLH ... Diagnosis #Management #Hematology
Monoclonal Gammopathy of Renal Significance (MGRS)

MGRS
• MGRS refers to kidney disease caused by nephrotoxic monoclonal immunoglobulins
meet criteria for hematologic ... or evolve into hematologic ... CT/PET imaging may ... guide subtype classification ... Complement pathway activation